ArticleBMJ open2025

Safety and immunogenicity of rVSVΔG-ZEBOV-GP vaccination when dosed concurrent with mRNA COVID-19 vaccine booster doses in healthy African adults (EbolaCov): protocol for a phase IV, single-centre, single-blinded, randomised controlled trial.

Karishma Gokani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.